VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine. Cardiovasc Drugs Ther. 2016 Dec; 30(6):539-550.
View in:
PubMed
subject areas
Adenosine
Animals
Apoptosis Regulatory Proteins
CARD Signaling Adaptor Proteins
Cardiotonic Agents
Cyclooxygenase 2
Diabetes Mellitus, Experimental
Drug Synergism
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Interleukin-1beta
Interleukin-6
Lipoxins
Male
Myocardial Reperfusion Injury
Myocardium
NLR Family, Pyrin Domain-Containing 3 Protein
Obesity
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists
Rats, Zucker
RNA, Messenger
Rosuvastatin Calcium
authors with profiles
YOCHAI BIRNBAUM